"Groundbreaking Adaptive Clinical Trial Aims to Reverse Neurological Damage in Progressive Multiple Sclerosis Patients" – The Republic Monitor
In a pioneering effort to address the limited treatment options for Australians grappling with progressive multiple sclerosis (MS), a groundbreaking adaptive clinical trial named PLATYPUS (PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis) is set to commence in January 2024. The initiative, boasting an initial funding of $4 million, marks the first-ever adaptive […]
Source: republicmonews.com
